Taro Pharmaceutical Industries Ltd (TARO) reported a profit for second quarter that declined from last year.
The company's earnings came in at $23.32 million, or $0.62 per share. This compares with $45.13 million, or $1.18 per share, in last year's second quarter.
Excluding items, Taro Pharmaceutical Industries Ltd reported adjusted earnings of $24.70 million or $0.66 per share for the period.
The company's revenue for the quarter fell 7.6% to $131.99 million from $142.84 million last year.
Taro Pharmaceutical Industries Ltd earnings at a glance:
-Earnings (Q2): $24.70 Mln. vs. $45.10 Mln. last year.-EPS (Q2): $0.66 vs. $1.18 last year.-Revenue (Q2): $131.99 Mln vs. $142.84 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.